Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses
about
Clinical significance of hepatitis C virus genotypesStatus of hepatitis C virus vaccination: Recent updateNeutralizing antibody response to hepatitis C virusImpaired antibody response causes persistence of prototypic T cell-contained virusIdentification of a domain containing B-cell epitopes in hepatitis C virus E2 glycoprotein by using mouse monoclonal antibodies.Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli.Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus.Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitisHuman serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infectionImmunity in chimpanzees chronically infected with hepatitis C virus: role of minor quasispecies in reinfectionLong-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort.Evolution of hypervariable region 1 of hepatitis C virus in primary infectionHuman monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopesGenetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy.Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: studies of infected donor-recipient clustersHypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees.Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3Dominant role of host selective pressure in driving hepatitis C virus evolution in perinatal infection.Generation and characterization of a hepatitis C virus NS3 protease-dependent bovine viral diarrhea virusEnhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapyNonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsetsAntigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes.Production and Characterization of Monoclonal Antibodies Specific for a Conserved Epitope within Hepatitis C Virus Hypervariable Region 1Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variantsStealth and cunning: hepatitis B and hepatitis C viruses.Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients.Antigenic structure of the hepatitis C virus envelope 2 proteinUpdate on chronic viral hepatitisMonitoring of Hepatitis C Virus Quasispecies in Chronic Infection by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Mutation DetectionA focus reduction neutralization assay for hepatitis C virus neutralizing antibodiesHLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine releaseDNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsidEpitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virusHigh levels of subgenomic HCV plasma RNA in immunosilent infectionsIsolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C VirusHepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune ResponsesMulticycle infection of hepatitis C virus in cell culture and inhibition by alpha and beta interferonsHepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis CSeparation of Hepatitis C genotype 4a into IgG-depleted and IgG-enriched fractions reveals a unique quasispecies profile
P2860
Q24514512-44B41816-C062-4599-830B-F0D9EF50DB25Q26774612-A47BFE2F-A0F2-4B2F-872E-61D1E15EB7AAQ27027484-11C1CB33-A89C-42BD-9010-B22BB40FBE84Q27331309-4D84F1A6-466E-43AB-AD5E-18769A74E925Q27469334-4A0E6F26-082D-4F68-A508-68E8263F92CCQ27469346-197A53DE-B9F8-4765-9C22-879F6D4E2990Q27469355-3DCBB511-79CC-4AAE-8304-ABF6ECAE0D3AQ27469459-CA699749-3A37-4D34-97B9-1E53404FF337Q27469507-13F8068F-D46F-4E43-B8A1-0F015F61B574Q27469524-F8780A0F-79D6-49CD-B71C-669DC5AC3B10Q27469567-03221937-F12F-410D-B8CD-432D8372C6C7Q27469585-071C2CED-001A-46E4-AF25-D7C668874D9DQ27469599-AEC83A68-18D2-4569-874F-76F2CDF15675Q27469620-F452F540-4024-41FD-B653-2D8F53C37577Q27469638-A1616E3D-622F-438F-B202-FF7FD2BB687DQ27469647-ADA8C42C-EEC4-48FF-A1E6-6C5316D24153Q27469660-093FAB5D-8A79-4C89-AD08-E9D904E58E51Q27469661-4E2480D9-DEE6-4B3A-B400-F6F15EF61EC9Q27469675-8BA74CFE-12A9-4F5E-B0D1-4D0020E641A1Q27469698-FFB73D6F-98DD-40E0-8B9B-B3E058EC0591Q27469719-7D293999-AE93-4207-9C98-442D3B56B1EDQ27469739-9C7E74C9-8086-48ED-8A2A-4B7CB40157CEQ27469889-818406A4-A556-4CCA-997F-D5AAD0645462Q27470002-A4857869-431E-4839-94D9-BB3182B8BD62Q27470086-A4427515-2564-41F6-B59F-9742A06DC50DQ27470232-249AB2B2-6679-44A7-9F6A-427EA5B98A3FQ27472543-C32BFB87-501C-45EA-AE35-29AEB779C085Q27473441-1406E9AF-96C4-45B6-8DFD-948E2339ADC5Q27477892-64223375-7B29-4CD2-85C8-4CE0392809E1Q27478186-4B78DB27-797B-4203-A53A-764C11FF1671Q27478295-82BC0B18-A37A-46D1-AD73-DFD07F01646AQ27478341-FB96638A-717F-44F5-BA0E-2425F3C731CCQ27480298-03A2149F-5B53-4EFD-9859-E200C2D7FBEDQ27480822-5E2F2B72-1C84-4E3D-8812-0971F8738E06Q27481224-77E37E04-5547-4F29-83C8-85532B95EA49Q27485325-D879E466-1AB3-4185-8AEC-D1765D618730Q27485419-E59C1AD4-E0FC-43D2-A7CF-0B3A6006200CQ27486010-1E5DE858-FBDB-430D-91F3-0FE4FA952B69Q27486537-361EA799-FB51-4867-8BAC-1CECEA41680AQ27487004-97B025AA-9746-4C3E-B627-93681F8C2202
P2860
Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Neutralizing antibodies agains ...... lization escape mutant viruses
@ast
Neutralizing antibodies agains ...... lization escape mutant viruses
@en
Neutralizing antibodies agains ...... lization escape mutant viruses
@nl
type
label
Neutralizing antibodies agains ...... lization escape mutant viruses
@ast
Neutralizing antibodies agains ...... lization escape mutant viruses
@en
Neutralizing antibodies agains ...... lization escape mutant viruses
@nl
prefLabel
Neutralizing antibodies agains ...... lization escape mutant viruses
@ast
Neutralizing antibodies agains ...... lization escape mutant viruses
@en
Neutralizing antibodies agains ...... lization escape mutant viruses
@nl
P2093
P2860
P1433
P1476
Neutralizing antibodies agains ...... lization escape mutant viruses
@en
P2093
P2860
P304
P577
1994-03-01T00:00:00Z